Marksans Pharma shares dropped after weak results

livemint.com

Marksans Pharma shares plunged 14% to a four-month low after reporting a significant drop in net profit for the June quarter. The company's net profit fell 35.8% year-on-year to ₹58.2 crore, impacted by weak performance in the UK and Europe, and Australia and New Zealand. Despite regional challenges, total revenue grew 5% year-on-year to ₹620 crore, driven by a 30.6% revenue increase in the US market.


With a significance score of 1.1, this news ranks in the top 52% of today's 28936 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Marksans Pharma shares dropped after weak results | News Minimalist